Contact
Please use this form to send email to PR contact of this press release:
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action – FENC
TO: